Sanofi-Aventis To Expand Operations In China
This article was originally published in PharmAsia News
Executive Summary
France's Sanofi-Aventis plans to use a new agreement with the Shanghai Institute for Biological Sciences to expand its research and development facility and step up that work in China. The agreement calls for a focus on discovering and developing drugs to treat cancer, diabetes, and problems of the nervous systems. The agreement in Shanghai coincides with completion by the end of this year of the firm's biometrics center in Beijing, aimed at providing support for global and local clinical trials. (Click here for more